UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Explanatory Note
This Amendment No. 1 (the “Amendment”) to the Current Report on Form 8-K amends Item 3.02 of the Current Report on Form 8-K filed on August 16, 2021 (the “Original Form 8-K”) solely to correct an inadvertent error regarding the date of conversion of certain Multiple Voting Shares, no par value per share (“MVS”). As previously filed, the Original Form 8-K incorrectly stated that 68,486.70 MVS were converted into Subordinate Voting Shares, no par value per share (“SVS”) during the period August 4, 2021 through August 13, 2021. 3,157.5 of such MVS were converted into 315,750 SVS on August 16, 2021 rather than August 13, 2021; accordingly, 65,329.20 MVS were converted into 6,532,920 SVS during the period August 4, 2021 through August 13, 2021. Except as expressly set forth in this explanatory note, the Amendment does not otherwise amend, modify or update the disclosures contained in the Original Form 8-K.
Item 3.02 | Unregistered Sales of Equity Securities |
During the period August 4, 2021 through August 13, 2021, holders of Multiple Voting Shares, no par value per share (“MVS”), of Harvest Health & Recreation Inc. (the “Company”), converted an aggregate of 65,329.20 shares of MVS to Subordinate Voting Shares, no par value (“SVS”), of the Company resulting in the issuance of 6,532,920 SVS by the Company. In accordance with their terms, MVS are convertible into SVS on a 1:100 basis. The holders of certain shares of SVS remain subject to individually negotiated lock-up agreements. The Company did not receive any cash proceeds as a result of the exchange of the MVS for the SVS, and the shares of MVS exchanged have been retired and cancelled. The issuance of SVS was made by the Company pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, contained in Section 3(a)(9) of such act on the basis that these offers constituted an exchange with existing holders of the Company’s securities, and no commission or other remuneration was paid to any party for soliciting such exchange.
During the same period, the Company issued an aggregate of 7,485,559 SVS as a result of the exercise of certain outstanding warrants issued by the Company in the past to various investors (the “Warrant Holders”). As a result of the exercise of the warrants, the Company received gross cash proceeds of USD $15,988,310.55 and CDN$1,138,506.64. The Warrant Holders exercised the warrants at exercise prices of USD$2.29 and CDN$2.26.
The issuances of SVS in connection with the warrant exercises were made by the Company pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, contained in Section 4(a)(2) and Regulation D promulgated thereunder or Regulation S promulgated thereunder, as applicable, each for transactions by an issuer not involving a public offering.
This current report on Form 8-K does not constitute an offer to exchange any securities of the Company for SVS, MVS or other securities of the Company.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HARVEST HEALTH & RECREATION INC. | ||
(Registrant) | ||
By: | /s/ Steven M. White | |
Steven M. White | ||
Chief Executive Officer |
Dated: August 18, 2021